Archford Capital Strategies, LLC Danaher Corp Transaction History

Archford Capital Strategies, LLC

  • $681 Million
  • Q3 2024

A detailed history of Archford Capital Strategies, LLC transactions in Danaher Corp stock. As of the latest transaction made, Archford Capital Strategies, LLC holds 1,661 shares of DHR stock, worth $394,786. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,661
Previous 1,655 0.36%
Holding current value
$394,786
Previous $413,000 11.62%
% of portfolio
0.07%
Previous 0.07%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024
BUY
$239.25 - $280.76 $1,435 - $1,684
6 Added 0.36%
1,661 $461,000
Q2 2024

Jul 17, 2024
SELL
$235.51 - $267.98 $2,826 - $3,215
-12 Reduced 0.72%
1,655 $413,000
Q1 2024

Apr 24, 2024
BUY
$224.58 - $256.19 $32,564 - $37,147
145 Added 9.53%
1,667 $416,000
Q4 2023

Jan 12, 2024
SELL
$185.1 - $233.13 $20,731 - $26,110
-112 Reduced 6.85%
1,522 $352,000
Q3 2023

Oct 27, 2023
SELL
$233.08 - $265.59 $134,487 - $153,245
-577 Reduced 26.1%
1,634 $405,000
Q2 2023

Aug 02, 2023
SELL
$224.99 - $256.14 $163,342 - $185,957
-726 Reduced 24.72%
2,211 $530,000
Q1 2023

Apr 18, 2023
BUY
$239.75 - $277.0 $56,101 - $64,818
234 Added 8.66%
2,937 $740,000
Q4 2022

Jan 26, 2023
SELL
$241.42 - $282.29 $28,004 - $32,745
-116 Reduced 4.11%
2,703 $0
Q3 2022

Oct 17, 2022
BUY
$247.06 - $1507.4 $247 - $1,507
1 Added 0.04%
2,819 $728,000
Q2 2022

Jul 12, 2022
SELL
$237.11 - $299.66 $48,370 - $61,130
-204 Reduced 6.75%
2,818 $715,000
Q1 2022

Apr 18, 2022
SELL
$257.27 - $315.76 $101,621 - $124,725
-395 Reduced 11.56%
3,022 $869,000
Q4 2021

Jan 20, 2022
SELL
$292.08 - $329.01 $97,846 - $110,218
-335 Reduced 8.93%
3,417 $1.12 Million
Q3 2021

Oct 14, 2021
BUY
$272.21 - $332.43 $544 - $664
2 Added 0.05%
3,752 $1.14 Million
Q2 2021

Jul 23, 2021
SELL
$225.08 - $271.69 $488,648 - $589,838
-2,171 Reduced 36.67%
3,750 $1.01 Million
Q1 2021

Apr 26, 2021
SELL
$212.38 - $245.9 $93,022 - $107,704
-438 Reduced 6.89%
5,921 $1.44 Million
Q4 2020

Jan 19, 2021
BUY
$212.5 - $245.46 $35,275 - $40,746
166 Added 2.68%
6,359 $1.55 Million
Q3 2020

Oct 19, 2020
SELL
$177.16 - $215.33 $23,030 - $27,992
-130 Reduced 2.06%
6,193 $1.33 Million
Q2 2020

Jul 24, 2020
SELL
$128.7 - $176.83 $43,114 - $59,238
-335 Reduced 5.03%
6,323 $1.12 Million
Q1 2020

Apr 29, 2020
BUY
$121.39 - $169.05 $242 - $338
2 Added 0.03%
6,658 $922,000
Q4 2019

Jan 15, 2020
SELL
$133.47 - $153.48 $7,340 - $8,441
-55 Reduced 0.82%
6,656 $1.02 Million
Q3 2019

Oct 23, 2019
BUY
$135.4 - $146.47 $4,332 - $4,687
32 Added 0.48%
6,711 $969,000
Q2 2019

Jul 18, 2019
SELL
$124.88 - $143.73 $144,111 - $165,864
-1,154 Reduced 14.73%
6,679 $955,000
Q1 2019

May 13, 2019
BUY
$97.62 - $132.29 $54,179 - $73,420
555 Added 7.63%
7,833 $1.03 Million
Q4 2018

Feb 13, 2019
BUY
$94.85 - $109.54 $16,883 - $19,498
178 Added 2.51%
7,278 $751,000
Q3 2018

Nov 14, 2018
SELL
$98.13 - $108.9 $89,200 - $98,990
-909 Reduced 11.35%
7,100 $772,000
Q2 2018

Aug 14, 2018
BUY
$96.1 - $103.24 $769,664 - $826,849
8,009 New
8,009 $790,000
Q1 2018

May 14, 2018
SELL
$92.16 - $103.8 $818,841 - $922,263
-8,885 Closed
0 $0
Q4 2017

Feb 16, 2018
SELL
$85.26 - $94.62 $10,657 - $11,827
-125 Reduced 1.39%
8,885 $825,000
Q3 2017

Nov 17, 2017
SELL
$79.29 - $88.45 $57,960 - $64,656
-731 Reduced 7.5%
9,010 $773,000
Q2 2017

Aug 18, 2017
BUY
N/A
8,415 Added 634.62%
9,741 $822,000
Q2 2017

Aug 18, 2017
BUY
N/A
1,326
1,326 $98,000

Others Institutions Holding DHR

# of Institutions
2,510
Shares Held
542M
Call Options Held
7.07M
Put Options Held
4.55M
View Full List

About DANAHER CORP

DHR Quotes by TradingView
  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $173B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Archford Capital Strategies, LLC Portfolio

Follow Archford Capital Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Archford Capital Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Archford Capital Strategies, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email